Qiagen Pays $28.5M Cash For Molecular Staging Technology Sep. 29, 2004 By Cormac Sheridan Qiagen NV is paying $28.5 million in cash to acquire whole-genome amplification technology from Molecular Staging Inc. (BioWorld International)Read More
Karo Bio Seeking SEK96M, Cutting 20 R&D Employees Sep. 15, 2004 By Cormac Sheridan Karo Bio AB is laying off 20 staff members as part of an overall effort to re-orient the company toward clinical development. (BioWorld International)Read More
Karo Bio Seeking SEK96M, Cutting 20 R&D Employees Sep. 15, 2004 By Cormac Sheridan Karo Bio AB is laying off 20 staff members as part of an overall effort to re-orient the company toward clinical development. (BioWorld International)Read More
